BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 28651173)

  • 1. Development, validation and clinical application of a method for the simultaneous quantification of lamivudine, emtricitabine and tenofovir in dried blood and dried breast milk spots using LC-MS/MS.
    Waitt C; Diliiy Penchala S; Olagunju A; Amara A; Else L; Lamorde M; Khoo S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1060():300-307. PubMed ID: 28651173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of an LC-MS/MS assay to simultaneously monitor the intracellular active metabolites of tenofovir, emtricitabine, and lamivudine in dried blood spots.
    Schauer AP; Sykes C; Cottrell ML; Prince H; Kashuba ADM
    J Pharm Biomed Anal; 2018 Feb; 149():40-45. PubMed ID: 29100029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma and breast milk pharmacokinetics of emtricitabine, tenofovir and lamivudine using dried blood and breast milk spots in nursing African mother-infant pairs.
    Waitt C; Olagunju A; Nakalema S; Kyohaire I; Owen A; Lamorde M; Khoo S
    J Antimicrob Chemother; 2018 Apr; 73(4):1013-1019. PubMed ID: 29309634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective determination of antiretroviral agents tenofovir, emtricitabine, and lamivudine in human plasma by a LC-MS-MS method for a bioequivalence study in healthy Indian subjects.
    Yadav M; Singhal P; Goswami S; Pande UC; Sanyal M; Shrivastav PS
    J Chromatogr Sci; 2010 Oct; 48(9):704-13. PubMed ID: 20875231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots.
    Olagunju A; Amara A; Waitt C; Else L; Penchala SD; Bolaji O; Soyinka J; Siccardi M; Back D; Owen A; Khoo S
    J Antimicrob Chemother; 2015 Oct; 70(10):2816-22. PubMed ID: 26108608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emtricitabine-Triphosphate in Dried Blood Spots as a Marker of Recent Dosing.
    Castillo-Mancilla J; Seifert S; Campbell K; Coleman S; McAllister K; Zheng JH; Gardner EM; Liu A; Glidden DV; Grant R; Hosek S; Wilson CM; Bushman LR; MaWhinney S; Anderson PL
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6692-6697. PubMed ID: 27572401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The simultaneous assay of tenofovir and emtricitabine in plasma using LC/MS/MS and isotopically labeled internal standards.
    Delahunty T; Bushman L; Robbins B; Fletcher CV
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Jul; 877(20-21):1907-14. PubMed ID: 19493710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strong Correlation Between Concentrations of Tenofovir (TFV) Emtricitabine (FTC) in Hair and TFV Diphosphate and FTC Triphosphate in Dried Blood Spots in the iPrEx Open Label Extension: Implications for Pre-exposure Prophylaxis Adherence Monitoring.
    Gandhi M; Glidden DV; Liu A; Anderson PL; Horng H; Defechereux P; Guanira JV; Grinsztejn B; Chariyalertsak S; Bekker LG; Grant RM;
    J Infect Dis; 2015 Nov; 212(9):1402-6. PubMed ID: 25895984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the Sample Card And Prep DBS System.
    Ganz N; Singrasa M; Nicolas L; Gutierrez M; Dingemanse J; Döbelin W; Glinski M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():50-60. PubMed ID: 22227055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a LC-MS/MS method for the quantification of tenofovir and emtricitabine in seminal plasma.
    Illamola SM; Valade E; Hirt D; Dulioust E; Zheng Y; Wolf JP; Tréluyer JM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1033-1034():234-241. PubMed ID: 27571683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of a liquid chromatography-MS/MS method for simultaneous quantification of tenofovir and efavirenz in biological tissues and fluids.
    Barreiros L; Cunha-Reis C; Silva EMP; Carvalho JRB; das Neves J; Sarmento B; Segundo MA
    J Pharm Biomed Anal; 2017 Mar; 136():120-125. PubMed ID: 28073073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High throughput LC-MS/MS method for simultaneous determination of tenofovir, lamivudine and nevirapine in human plasma.
    Valluru RK; B PB; S KS; V PK; Kilaru NB
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():117-26. PubMed ID: 23774246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation of tenofovir and emtricitabine in dried blood spots (DBS) with LC-MS/MS.
    Zheng JH; Guida LA; Rower C; Castillo-Mancilla J; Meditz A; Klein B; Kerr BJ; Langness J; Bushman L; Kiser J; Anderson PL
    J Pharm Biomed Anal; 2014 Jan; 88():144-51. PubMed ID: 24055850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development, validation and clinical application of a novel method for the quantification of efavirenz in dried breast milk spots using LC-MS/MS.
    Olagunju A; Bolaji OO; Amara A; Waitt C; Else L; Soyinka J; Adeagbo B; Adejuyigbe E; Siccardi M; Back D; Owen A; Khoo S
    J Antimicrob Chemother; 2015 Feb; 70(2):555-61. PubMed ID: 25326089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of an assay for the simultaneous determination of zidovudine, abacavir, emtricitabine, lamivudine, tenofovir and ribavirin in human plasma using liquid chromatography-tandem mass spectrometry.
    Kromdijk W; Pereira SA; Rosing H; Mulder JW; Beijnen JH; Huitema AD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Mar; 919-920():43-51. PubMed ID: 23411018
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous determination of intracellular concentrations of tenofovir, emtricitabine, and dolutegravir in human brain microvascular endothelial cells using liquid chromatography-tandem mass spectrometry (LC-MS/MS).
    Patel SH; Ismaiel OA; Mylott WR; Yuan M; Hauser KF; McRae M
    Anal Chim Acta; 2019 May; 1056():79-87. PubMed ID: 30797464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of an LC-MS/MS assay for tenofovir and tenofovir alafenamide in human plasma and cerebrospinal fluid.
    Ocque AJ; Hagler CE; Morse GD; Letendre SL; Ma Q
    J Pharm Biomed Anal; 2018 Jul; 156():163-169. PubMed ID: 29709783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography/high-resolution accurate mass spectrometry.
    Oliveira RV; Henion J; Wickremsinhe ER
    Rapid Commun Mass Spectrom; 2014 Nov; 28(22):2415-26. PubMed ID: 25303470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of nucleoside analog mono-, di-, and tri-phosphates in cellular matrix by solid phase extraction and ultra-sensitive LC-MS/MS detection.
    Bushman LR; Kiser JJ; Rower JE; Klein B; Zheng JH; Ray ML; Anderson PL
    J Pharm Biomed Anal; 2011 Sep; 56(2):390-401. PubMed ID: 21715120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of dried matrix spots and fabric phase sorptive extraction methods for quantification of highly potent analgesic activity agent (2R,4aR,7R,8aR)-4,7-dimethyl-2-(thiophen-2-yl)octahydro-2H-chromen-4-ol in rat whole blood and plasma using LC-MS/MS.
    Lastovka AV; Rogachev AD; Il'ina IV; Kabir A; Volcho KP; Fadeeva VP; Pokrovsky AG; Furton KG; Salakhutdinov NF
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Nov; 1132():121813. PubMed ID: 31706184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.